Analyst Ratings for HCA Healthcare Inc (HCA)
HCA Rating Summary
HCA Price Target Summary
- Highest: $579.00 (UBS)
- Lowest: $380.00 (Morgan Stanley)
- Average: $465.76
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$465.76 (+12.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$465.76 (+12.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2026 | Barclays » Updated 7/27/2026 |
Andrew Mok | Downgrade | Equalweight (Overweight) |
387.00 (402.00) |
423.11 (413.58) |
-2.25% | Details |
| 12/15/2025 | Morgan Stanley » Updated 7/27/2026 |
Craig Hettenbach | Downgrade | Underweight (Equalweight) |
380.00 (425.00) |
482.35 (413.58) |
-14.26% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
